Exelixis
EXEL
#1752
Rank
โ‚ฌ9.77 B
Marketcap
36,31ย โ‚ฌ
Share price
1.36%
Change (1 day)
9.86%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company